Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells
Blood Adv
.
2024 Nov 26;8(22):5880-5884.
doi: 10.1182/bloodadvances.2024012762.
Authors
Mehmet H Kocoglu
1
2
3
,
Tim Luetkens
1
3
4
,
Jacqueline T Bork
1
4
5
,
John Baddley
1
5
6
,
Destiny Omili
1
3
,
Etse Gebru
1
3
,
Rediet Mulatu
1
3
,
Daniel Yamoah
1
3
,
Thierry Iraguha
1
3
,
Xiaoxuan Fan
1
4
,
Patricia Lesho
1
,
Mohammad Yousaf
1
,
Jillian M Baker
4
,
Kenneth A Dietze
4
,
Kim G Hankey
1
2
3
,
Ashraf Badros
1
2
3
,
Jean A Yared
1
2
3
,
Aaron P Rapoport
1
2
3
,
Nancy M Hardy
1
2
3
,
Djordje Atanackovic
1
2
3
4
Affiliations
1
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
2
Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
3
Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
4
Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.
5
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.
6
Divison of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD.
PMID:
39058975
PMCID:
PMC11612371
DOI:
10.1182/bloodadvances.2024012762
No abstract available